Clinical Trial: A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07836140) titled 'A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.' on Sept. 17.

Brief Summary: An Investigator-Initiated, Randomized, Open-Label, Active-Controlled Study Comparing the Effects of BGM0504 Injection versus Semaglutide Injection on Insulin Sensitivity and Body Weight in Obese Subjects

Study Start Date: April 22, 2024

Study Type: INTERVENTIONAL

Condition: Obesity / Overweight

Intervention: DRUG: semaglutide

Multiple ascending doses of semaglutide administered SC

DRUG: BGM0504 Administered SC

Multiple ascending doses of BGM0504 administered SC

Recruitment Status: COMPLETED

Sponsor...